Company / Interest Expense
Bionano Genomics, Inc. Interest Expense History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.1M
FY2023
5-year range
$298.0K / $5.1M
FY2019-FY2023
Trend
+1617.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed +1618% YoY in FY2023, a notable deviation from the 5-year average annual change of +312%.
Based on SEC 10-K filings.
$5M in FY2023 with a 5-year CAGR of +30.0%.
Increased from $927,000 to $5M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +26.7%
- 5-Year CAGR
- +30.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +30.0%, indicating consistent growth.
- In FY2023, interest expense increased 1617.8% year-over-year.
- Lowest interest expense in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $5.1M | +1617.8% |
| FY2022 | $298.0K | -67.9% |
| FY2021 | $927.0K | -63.2% |
| FY2020 | $2.5M | +10.2% |
| FY2019 | $2.3M | +65.5% |
| FY2018 | $1.4M | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 22, 2026